会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Tetrahydronaphthofuranone derivatives and process for producing the same
    • 四氢萘并呋喃酮衍生物及其制备方法
    • US06255339B1
    • 2001-07-03
    • US09117070
    • 1998-07-21
    • Kenichi KuriharaRie ShineiKiyoshi TanabeYasuo YamamotoKeiichi AjitoKaori MiyajimaYuji TabataShohei YasudaKuniaki TatsutaTsuneo Okonogi
    • Kenichi KuriharaRie ShineiKiyoshi TanabeYasuo YamamotoKeiichi AjitoKaori MiyajimaYuji TabataShohei YasudaKuniaki TatsutaTsuneo Okonogi
    • A61K3134
    • C07D307/92C07D407/12C07D407/14C07D409/12C07D417/12
    • Compounds represented by the following formula (I) and pharmaceutically acceptable salts thereof are disclosed. The compounds have progesterone receptor binding inhibitory activity and, hence, can be used as therapeutic and prophylactic agents for progesterone-related diseases. Specifically, they are useful as abortifacients, oral contraceptive pills, carcinostatic agents for breast cancer and ovarian cancer, therapeutic agents for endometriosis, meningioma, and myeloma, and therapeutic and prophylactic agents for osteoporosis and climacteric disturbance. wherein R1 and R2 represent a hydroxyl group, alkyloxy, alkenyloxy, alkynyloxy, cycloalkyloxy, alkoxyalkyloxy, cycloalkyloxy containig one oxygen atom, aralkyloxy, alkylcarbonyloxy, alkenylcarbonyloxy, alkynylcarbonyloxy, cycloalkylcarbonyloxy, alkoxycarbonyloxy, aryloxy carbonyloxy, aralkylcarbonyloxy, aromatic acyloxy, heteroaromatic acyloxy, saturated heterocyclic carbonyloxy, alkylsulfonyloxy, aromatic sulfonyloxy, alkylcarbamoyloxy, aromatic carbamoyloxy, alkylcarbonylamino, or aromatic acylamino, provided that R1 may further represent a hydrogen atom, alkyl, alkenyl, or alkynyl; and R3, R4, and R5 each independently represent a hydrogen atom, alkyl or alkenyl.
    • 公开了由下式(I)表示的化合物及其药学上可接受的盐。 所述化合物具有孕酮受体结合抑制活性,因此可用作孕酮相关疾病的治疗和预防剂。 具体地说,它们可用作流产者,口服避孕药,乳腺癌和卵巢癌的制癌剂,子宫内膜异位症的治疗剂,脑膜瘤和骨髓瘤,以及骨质疏松症和更年期障碍的治疗和预防剂。其中R1和R2表示羟基, 烷氧基,链烯氧基,炔氧基,环烷氧基,烷氧基烷氧基,含有一个氧原子的环烷氧基,芳烷氧基,烷基羰基氧基,链烯基羰基氧基,炔基羰氧基,环烷基羰基氧基,烷氧基羰基氧基,芳氧基羰基氧基,芳烷基羰基氧基,芳香酰氧基,杂芳基酰氧基,饱和杂环羰氧基,烷基磺酰氧基,芳香磺酰氧基,烷基氨基甲酰氧基, 芳族氨基甲酰氧基,烷基羰基氨基或芳族酰氨基,条件是R 1可以进一步代表氢原子,烷基,烯基或炔基; 并且R 3,R 4和R 5各自独立地表示氢原子,烷基或链烯基。
    • 2. 发明授权
    • Tetrahydrobenzindolone derivatives
    • 四氢苯并吲哚酮衍生物
    • US6077840A
    • 2000-06-20
    • US331294
    • 1999-06-18
    • Kenichi KuriharaRie ShineiYasushi KurataYuji TabataKiyoshi TanabeTsuneo Okonogi
    • Kenichi KuriharaRie ShineiYasushi KurataYuji TabataKiyoshi TanabeTsuneo Okonogi
    • C07D209/60C07D401/12C07D403/12C07D405/12C07D409/12C07D521/00A61K31/535A61K31/40A61K31/44A61K31/50C07D233/02
    • C07D231/12C07D209/60C07D233/56C07D249/08C07D401/12C07D403/12C07D405/12C07D409/12
    • Compounds represented by the following formula (I) or pharmaceutically acceptable salts thereof and a process for producing the same are disclosed. The compounds have progesterone receptor binding inhibitory activity and, hence, can be used as therapeutic and prophylactic agents for progesterone-related diseases. Specifically, they are useful as carcinostatic agents for breast cancer and ovarian cancer, therapeutic agents for hysteromyoma, endometriosis, meningioma, and myeloma, abortifacients, oral contraceptive pills, and therapeutic and prophylactic agents for osteoporosis and climacteric disturbance. ##STR1## wherein R.sup.1 represents alkyl or aralkyl; R.sup.2 represents a hydrogen atom, alkylcarbonyl, cycloalkylcarbonyl, aromatic acyl, heteroaromatic acyl, saturated heterocyclic acyl, alkyl, alkenyl, aralkyl, carbamoyl, alkylcarbamoyl, aromatic carbamoyl, aralkylcarbamoyl, alkylaminocarbonyl, cycloalkylcarbamoyl, alkoxycarbonyl, aryloxycarbonyl, heteroaromatic thiocarbonyl, saturated heterocyclic thiocarbonyl, or alkyl-thiocarbamoyl: and R.sup.3 represents a hydrogen atom, a hydroxyl group, alkyloxy, alkylcarbonyloxy, alkylthio, or arylthio.
    • PCT No.PCT / JP97 / 04683 Sec。 371日期:1999年6月18日 102(e)1999年6月18日PCT 1997年12月18日PCT公布。 第WO98 / 27059号公报 日期:1998年6月25日公开了由下式(I)表示的化合物或其药学上可接受的盐及其制备方法。 所述化合物具有孕酮受体结合抑制活性,因此可用作孕酮相关疾病的治疗和预防剂。 具体地说,它们可用作乳腺癌和卵巢癌的制癌剂,子宫肌瘤,子宫内膜异位症,脑膜瘤和骨髓瘤的治疗剂,流产者,口服避孕药以及用于骨质疏松和更年期障碍的治疗和预防剂。 其中R1表示烷基或芳烷基; R 2表示氢原子,烷基羰基,环烷基羰基,芳香族酰基,杂芳基酰基,饱和杂环酰基,烷基,烯基,芳烷基,氨基甲酰基,烷基氨基甲酰基,芳香族氨基甲酰基,芳烷基氨基甲酰基,烷基氨基羰基,环烷基氨基甲酰基,烷氧基羰基,芳氧基羰基,杂芳硫基羰基,饱和杂环硫代羰基, 或烷基 - 硫代氨基甲酰基:和R3表示氢原子,羟基,烷氧基,烷基羰氧基,烷硫基或芳硫基。
    • 5. 发明授权
    • Process for the preparation of a 3-substituted thio-3-cephem compound
    • 3-取代的硫代-3-头孢烯化合物的制备方法
    • US5294705A
    • 1994-03-15
    • US853730
    • 1992-06-03
    • Yuichi YamamotoTsuneo OkonogiSeiji ShibaharaShigeharu Inoue
    • Yuichi YamamotoTsuneo OkonogiSeiji ShibaharaShigeharu Inoue
    • C07D501/00C07D501/04C07D501/59
    • C07D501/00Y02P20/55
    • An ester of 7-acylamido-3-acylthio-3- or -2-cephem-4-carboxylic acid represented by general formula (1) ##STR1## wherein R.sup.1 is an acyl group, R.sup.2 is a carboxyl-protecting group, R.sup.3 is a lower alkyl group, an aryl group or a substituted aryl group, or a mixture of two or more of said ester is used as the starting compound and is reacted wit a tertiary amine and also a secondary amine. Then the tertiary amine salt compound as formed as the reaction product is reacted with a compound of formula (4)R.sup.4 --X (4)wherein R.sup.4 is a lower alkyl group, a cycloalkyl group or a heterocyclic group or a heterocyclic group-substituted methyl group and X is a leaving group, whereby the desired ester of 7-acylamido-3-substituted thio-3-cephem-4-carboxylic acid of formula (5) ##STR2## can be produced preferentially, conveniently and efficiently.
    • PCT No.PCT / JP90 / 01599 Sec。 371日期:1992年6月3日 102(e)日期1992年6月3日PCT 1990年12月7日PCT PCT。 公开号WO91 / 09037 1991年6月27日,由通式(1)表示的7-酰基氨基-3-酰硫基-3-或2-头孢烯-4-羧酸酯(*化学结构*)(1)其中R1为 酰基,R2为羧基保护基,R3为低级烷基,芳基或取代芳基,或两种或多种所述酯的混合物用作起始化合物,并与叔胺 以及仲胺。 然后将作为反应产物形成的叔胺盐化合物与式(4)R4-X(4)的化合物反应,其中R4是低级烷基,环烷基或杂环基或杂环基取代的甲基 并且X是离去基团,由此可以优选地,方便地制备所需的式(5)的7-酰基酰胺基-3-取代的硫代-3-头孢烯-4-羧酸的酯(*化学结构*)(5) 并有效地。
    • 6. 发明授权
    • Cephalosporin derivatives
    • 头孢菌素衍生物
    • US4785090A
    • 1988-11-15
    • US704077
    • 1985-02-21
    • Takashi TsuruokaSeiji ShibaharaKatsuyoshi IwamatsuTsuneo OkonogiSatoru NakabayashiYasushi MuraiHiroko OginoKiyoaki KatanoTakashi YoshidaShigeharu InoueShunzo FukatsuShinichi Kondo
    • Takashi TsuruokaSeiji ShibaharaKatsuyoshi IwamatsuTsuneo OkonogiSatoru NakabayashiYasushi MuraiHiroko OginoKiyoaki KatanoTakashi YoshidaShigeharu InoueShunzo FukatsuShinichi Kondo
    • C07D213/64C07D213/68C07D221/04C07D501/36C07D501/38A61K31/545
    • C07D221/04C07D213/64C07D213/68
    • This is a class of antibacterial compounds of the formula: ##STR1## wherein Y is straight or branched alkyl or alkenyl chain, cycloalkanomethyl of 3-6 carbon atoms, each group being optionally substituted by halogen, or a group ##STR2## wherein n is 0 or an integer of 1-3, A is a group --COR.sup.3 wherein R.sup.3 is hydroxy, a group ##STR3## wherein R.sup.4 and R.sup.5, which may be the same or different, are hydrogen or alkyl of 1-5 carbon atoms, a group ##STR4## or a 5- or 6-membered heterocyclic group containing nitrogen and/or sulfur, and R.sup.1 and R.sup.2, which may be the same or different, are hydrogen, alkyl of 1-5 carbon atoms, or R.sup.1 and R.sup.2 may be combined together to form cycloalkylidene of 3-5 carbon atoms, and Z is a group of the formula: ##STR5## wherein m is 0 or an integer of 3-5, R.sup.6 is hydrogen or alkyl of 1-3 carbon atoms, and R.sup.7, when m is an integer of 3-5, is alkyl of 1-5 carbon atoms, alkenyl, cyclopropyl, a group --(CH.sub.2).sub.p B wherein p is 0 or an integer of 1-3 and B is amino, alkyl-substituted amino, hydroxy, carboxy, carbamoyl, trifluoromethyl, sulfonic acid, sulfonic acid amide, alkylthio or cyano or, when m is 0, is alkyl of 1-5 carbon atoms, which may optionally be substituted by halogen, alkenyl, a group ##STR6## wherein R.sup.8 is hydrogen, alkyl of 1-4 carbon atoms or phenyl, or cyclopropyl, and a salt thereof.
    • 这是一类具有下式的抗菌化合物:其中Y是直链或支链烷基或烯基链,3-6个碳原子的环烷基甲基,每个基团任选被卤素取代,或基团< 其中n为0或1-3的整数,A为基团-COR 3,其中R 3为羟基,其中R 4和R 5可以相同或不同,为氢或1-5碳的烷基 原子,基团或含有氮和/或硫的5-或6-元杂环基,R 1和R 2可以相同或不同,为氢,1-5个碳原子的烷基或R1 并且R 2可以组合在一起形成3-5个碳原子的亚烷基,Z是下式的基团:其中m是0或3-5的整数,R6是氢或1-3个碳的烷基 原子和R 7,当m是3-5的整数时,是1-5个碳原子的烷基,烯基,环丙基,基团 - (CH 2)pB,其中p是0或1-3的整数,B是氨基 ,烷基取代的氨基 羟基,羧基,氨基甲酰基,三氟甲基,磺酸,磺酸酰胺,烷硫基或氰基,或当m为0时,其为1-5个碳原子的烷基,其可任选被卤素,链烯基,基团 其中R8是氢,1-4个碳原子的烷基或苯基,或环丙基及其盐。